ProCE Banner Activity

New and Emerging Agents for Schizophrenia

Slideset Download
Slides from the schizophrenia presentation at the 8th Annual Psychopharmacology Update 2022

Released: November 28, 2022

Expiration: November 27, 2023

Begin Activity

Share

Faculty

Jonathan M. Meyer

Jonathan M. Meyer, MD

Voluntary Clinical Professor, Department of Psychiatry
University of California, San Diego
Psychopharmacology Consultant
Balboa Naval Medical Center First Episode Psychosis Program
State of Nevada Project ECHO First Episode Psychosis Program

Supporters

Supported by educational grants from

Independent Educational Activity

Faculty Disclosure

Primary Author

Jonathan M. Meyer, MD

Voluntary Clinical Professor, Department of Psychiatry
University of California, San Diego
Psychopharmacology Consultant
Balboa Naval Medical Center First Episode Psychosis Program
State of Nevada Project ECHO First Episode Psychosis Program

Jonathan M. Meyer, MD: consultant/advisor/speaker: Alkermes, Axsome, Cerevel, Intra-Cellular Therapies, Karuna, Neurocrine, Noven, Relmada, Teva.